{"pmid":32425182,"title":"[Risk communication during the COVID-19 pandemic: lessons for lifestyle interventions in cardiovascular prevention].","text":["[Risk communication during the COVID-19 pandemic: lessons for lifestyle interventions in cardiovascular prevention].","Lifestyle is a cornerstone of cardiovascular prevention and the process of risk communication constitutes an important step to obtain favorable changes in daily habits. Nevertheless, there is no definite consensus on how health operators should provide information on cardiovascular risk, and several models have been proposed in different settings. The current COVID-19 pandemic - with related communication strategies to reduce the spread of the disease and morbidity - may offer an interesting opportunity to reconsider communication in cardiovascular prevention: even though cardiovascular conditions are not communicable diseases, both COVID-19 and cardiac illnesses force a huge segment of the population to major lifestyle changes. This narrative commentary describes similarities between these conditions, mainly focusing on modalities of risk communication, strategies to counteract fake news, actions to enhance the expertise of health operators, and finally on new skills that could derive as a lesson from COVID-19.","G Ital Cardiol (Rome)","Angelino, Elisabetta","Ambrosetti, Marco","Fattirolli, Francesco","32425182"],"abstract":["Lifestyle is a cornerstone of cardiovascular prevention and the process of risk communication constitutes an important step to obtain favorable changes in daily habits. Nevertheless, there is no definite consensus on how health operators should provide information on cardiovascular risk, and several models have been proposed in different settings. The current COVID-19 pandemic - with related communication strategies to reduce the spread of the disease and morbidity - may offer an interesting opportunity to reconsider communication in cardiovascular prevention: even though cardiovascular conditions are not communicable diseases, both COVID-19 and cardiac illnesses force a huge segment of the population to major lifestyle changes. This narrative commentary describes similarities between these conditions, mainly focusing on modalities of risk communication, strategies to counteract fake news, actions to enhance the expertise of health operators, and finally on new skills that could derive as a lesson from COVID-19."],"journal":"G Ital Cardiol (Rome)","authors":["Angelino, Elisabetta","Ambrosetti, Marco","Fattirolli, Francesco"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425182","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1714/3359.33321","topics":["Prevention"],"weight":1,"_version_":1667252837674909696,"score":9.490897,"similar":[{"pmid":32371988,"title":"COVID-19 pandemic: the effects of quarantine on cardiovascular risk.","text":["COVID-19 pandemic: the effects of quarantine on cardiovascular risk.","COVID-19 is causing a global pandemic with a high number of deaths and infected people. To contain the diffusion of COVID-19 virus, Governments have enforced restrictions on outdoor activities or even collective quarantine on the population. One important consequence of quarantine is a change in lifestyle: reduced physical activity and unhealthy diet. 2019 guidelines for primary prevention of cardiovascular disease indicate that \"Adults should engage in at least 150 minute per week of accumulated moderate-intensity or 75 minute per week of vigorous-intensity aerobic physical activity (or an equivalent combination of moderate and vigorous activity) to reduce ASCVD risk.\" During quarantine, strategies to further increase home-based physical activity and to follow a healthy diet should be implemented. Quarantine carries some long-term effects on cardiovascular disease, mainly related to unhealthy lifestyle and anxiety. Following quarantine a global action supporting healthy diet and physical activity is mandatory to encourage people to return to good lifestyle.","Eur J Clin Nutr","Mattioli, Anna Vittoria","Ballerini Puviani, Matteo","Nasi, Milena","Farinetti, Alberto","32371988"],"abstract":["COVID-19 is causing a global pandemic with a high number of deaths and infected people. To contain the diffusion of COVID-19 virus, Governments have enforced restrictions on outdoor activities or even collective quarantine on the population. One important consequence of quarantine is a change in lifestyle: reduced physical activity and unhealthy diet. 2019 guidelines for primary prevention of cardiovascular disease indicate that \"Adults should engage in at least 150 minute per week of accumulated moderate-intensity or 75 minute per week of vigorous-intensity aerobic physical activity (or an equivalent combination of moderate and vigorous activity) to reduce ASCVD risk.\" During quarantine, strategies to further increase home-based physical activity and to follow a healthy diet should be implemented. Quarantine carries some long-term effects on cardiovascular disease, mainly related to unhealthy lifestyle and anxiety. Following quarantine a global action supporting healthy diet and physical activity is mandatory to encourage people to return to good lifestyle."],"journal":"Eur J Clin Nutr","authors":["Mattioli, Anna Vittoria","Ballerini Puviani, Matteo","Nasi, Milena","Farinetti, Alberto"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371988","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1038/s41430-020-0646-z","topics":["Prevention"],"weight":1,"_version_":1666138496470876161,"score":226.98297},{"pmid":32477021,"pmcid":"PMC7232897","title":"Lifestyle at Time of COVID-19: How Could Quarantine Affect Cardiovascular Risk.","text":["Lifestyle at Time of COVID-19: How Could Quarantine Affect Cardiovascular Risk.","COVID-19 is causing a global pandemic with a high number of deaths and infected people. To contain the diffusion of COVID-19 virus, governments have enforced restrictions on outdoor activities or even collective quarantine on the population. Quarantine carries some long-term effects on cardiovascular disease, mainly related to unhealthy lifestyle and anxiety.","Am J Lifestyle Med","Mattioli, Anna Vittoria","Ballerini Puviani, Matteo","32477021"],"abstract":["COVID-19 is causing a global pandemic with a high number of deaths and infected people. To contain the diffusion of COVID-19 virus, governments have enforced restrictions on outdoor activities or even collective quarantine on the population. Quarantine carries some long-term effects on cardiovascular disease, mainly related to unhealthy lifestyle and anxiety."],"journal":"Am J Lifestyle Med","authors":["Mattioli, Anna Vittoria","Ballerini Puviani, Matteo"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32477021","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1559827620918808","keywords":["covid-19","anxiety","cardiovascular risk factors","physical activity","prevention","quarantine"],"topics":["Prevention"],"weight":1,"_version_":1668532089539002368,"score":206.07892},{"pmid":32418463,"title":"Cardiovascular Disease Prevention and Implications of COVID-19: An Evolving Case Study in the Crescent City.","text":["Cardiovascular Disease Prevention and Implications of COVID-19: An Evolving Case Study in the Crescent City.","Medicine and public health have traditionally separated the prevention and treatment of communicable and non-communicable diseases. The coronavirus 2019 (COVID-19) pandemic has challenged this paradigm, particularly in the setting of cardiovascular disease (CVD). Overall, individuals with underlying CVD who acquire severe acute respiratory syndrome coronavirus 2 experience up to a ten-fold higher case-fatality rate compared to the general population. While the impact of the pandemic on cardiovascular health continues to evolve, few have defined this association from a frontline, public health perspective of populations disproportionately affected by CVD and COVID-19. Louisiana is ranked within the bottom five states for cardiovascular health, and is home to several parishes that have experienced among the highest COVID-19 case-fatality rates nationally. Here, we review CVD prevention and implications of COVID-19 in New Orleans, Louisiana, a city holding a sobering yet, resilient history with previous public health disasters. In particular, we discuss potential pandemic-driven changes in access to healthcare, preventive pharmacotherapy, and lifestyle behaviors, all of which may adversely affect CVD prevention and management, while amplifying racial disparities. Through this process, we highlight proposed recommendations for how CVD prevention efforts can be improved in midst of the current COVID-19 pandemic and future public health crises.","J Am Heart Assoc","Razavi, Alexander C","Kelly, Tanika N","He, Jiang","Fernandez, Camilo","Whelton, Paul K","Krousel-Wood, Marie","Bazzano, Lydia A","32418463"],"abstract":["Medicine and public health have traditionally separated the prevention and treatment of communicable and non-communicable diseases. The coronavirus 2019 (COVID-19) pandemic has challenged this paradigm, particularly in the setting of cardiovascular disease (CVD). Overall, individuals with underlying CVD who acquire severe acute respiratory syndrome coronavirus 2 experience up to a ten-fold higher case-fatality rate compared to the general population. While the impact of the pandemic on cardiovascular health continues to evolve, few have defined this association from a frontline, public health perspective of populations disproportionately affected by CVD and COVID-19. Louisiana is ranked within the bottom five states for cardiovascular health, and is home to several parishes that have experienced among the highest COVID-19 case-fatality rates nationally. Here, we review CVD prevention and implications of COVID-19 in New Orleans, Louisiana, a city holding a sobering yet, resilient history with previous public health disasters. In particular, we discuss potential pandemic-driven changes in access to healthcare, preventive pharmacotherapy, and lifestyle behaviors, all of which may adversely affect CVD prevention and management, while amplifying racial disparities. Through this process, we highlight proposed recommendations for how CVD prevention efforts can be improved in midst of the current COVID-19 pandemic and future public health crises."],"journal":"J Am Heart Assoc","authors":["Razavi, Alexander C","Kelly, Tanika N","He, Jiang","Fernandez, Camilo","Whelton, Paul K","Krousel-Wood, Marie","Bazzano, Lydia A"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32418463","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1161/JAHA.120.016997","keywords":["covid-19","cardiovascular disease prevention","coronavirus","diet","epidemiology","high blood pressure","hypertension","primary prevention","quarantine","race","telehealth"],"locations":["Louisiana","New Orleans","Louisiana","Crescent"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1667159284370112512,"score":203.8314},{"pmid":32401348,"title":"Maternal health and non-communicable disease prevention: An investment case for the post COVID-19 world and need for better health economic data.","text":["Maternal health and non-communicable disease prevention: An investment case for the post COVID-19 world and need for better health economic data.","An integrated approach to population health, disease surveillance, and preventive care will dominate the health agenda in the post COVID-19 world. Because of their huge burden and the vulnerability imposed during a health crisis, prevention and care of non-communicable diseases (NCDs) will need to be prioritized even further. Maternal and child health are inextricably linked with NCDs and their risk factors. The intergenerational impact of poor maternal nutrition and health conditions during pregnancy, particularly NCD-related pregnancy complications, can be considered as a multiplier of the ongoing pandemic of NCDs. The economic cost of poor maternal health and NCD-related pregnancy complications is likely very high, but is not adequately researched or documented in the context of long-term population health. Interventions to address NCDs in pregnancy have beneficial effects on short-term pregnancy outcomes; but even more importantly, identifying \"at-risk\" mothers and offspring opens up the opportunity for targeted early preventive action. Preventive actions to address obesity, hypertension, type 2 diabetes, and cardiovascular diseases have a common lifestyle approach-identifying any one of these problems in pregnancy provides an opportunity to address them all. Cost-benefit analyses that only focus on the short-term and on one condition do not capture the full value of downstream, long-term benefits for population health. This requires urgent attention from FIGO.","Int J Gynaecol Obstet","Kapur, Anil","Hod, Moshe","32401348"],"abstract":["An integrated approach to population health, disease surveillance, and preventive care will dominate the health agenda in the post COVID-19 world. Because of their huge burden and the vulnerability imposed during a health crisis, prevention and care of non-communicable diseases (NCDs) will need to be prioritized even further. Maternal and child health are inextricably linked with NCDs and their risk factors. The intergenerational impact of poor maternal nutrition and health conditions during pregnancy, particularly NCD-related pregnancy complications, can be considered as a multiplier of the ongoing pandemic of NCDs. The economic cost of poor maternal health and NCD-related pregnancy complications is likely very high, but is not adequately researched or documented in the context of long-term population health. Interventions to address NCDs in pregnancy have beneficial effects on short-term pregnancy outcomes; but even more importantly, identifying \"at-risk\" mothers and offspring opens up the opportunity for targeted early preventive action. Preventive actions to address obesity, hypertension, type 2 diabetes, and cardiovascular diseases have a common lifestyle approach-identifying any one of these problems in pregnancy provides an opportunity to address them all. Cost-benefit analyses that only focus on the short-term and on one condition do not capture the full value of downstream, long-term benefits for population health. This requires urgent attention from FIGO."],"journal":"Int J Gynaecol Obstet","authors":["Kapur, Anil","Hod, Moshe"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401348","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/ijgo.13198","keywords":["covid-19","health economics","health system transformation","maternal health","ncd pregnancy complications","non-communicable diseases"],"topics":["Prevention"],"weight":1,"_version_":1666714494993170432,"score":199.76952},{"pmid":32387230,"title":"When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19.","text":["When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19.","The world has faced an unprecedented challenge when coronavirus (COVID-19) emerged as a pandemic. Millions of people have contracted the virus and a significant number of them lost their lives, resulting in a tremendous social and economic shock across the globe. Amid the growing burden of the pandemic, there are parallel emergencies that need to be simultaneously tackled: the proliferation of fake medicines, fake news and medication misinformation surrounding COVID-19. Pharmacists are key health professionals with the required skills and training to contribute to the fight against these emergencies. Primarily, they can be a relevant source of accurate and reliable information to the public or other fellow health professionals thereby reducing the spread of COVID-19 medication misinformation. This can be achieved by providing accurate and reliable information based on recommendations given by relevant health authorities and professional associations to make sure the community understand the importance of the message and thus minimise the detrimental consequences of the pandemic. This commentary aims to summarise the existing literature in relation to the promising treatments currently under trial, the perils of falsified medications and medicine-related information and the role of pharmacists in taking a leading role in combating these parallel global emergencies.","Res Social Adm Pharm","Erku, Daniel A","Belachew, Sewunet A","Abrha, Solomon","Sinnollareddy, Mahipal","Thomas, Jackson","Steadman, Kathryn J","Tesfaye, Wubshet H","32387230"],"abstract":["The world has faced an unprecedented challenge when coronavirus (COVID-19) emerged as a pandemic. Millions of people have contracted the virus and a significant number of them lost their lives, resulting in a tremendous social and economic shock across the globe. Amid the growing burden of the pandemic, there are parallel emergencies that need to be simultaneously tackled: the proliferation of fake medicines, fake news and medication misinformation surrounding COVID-19. Pharmacists are key health professionals with the required skills and training to contribute to the fight against these emergencies. Primarily, they can be a relevant source of accurate and reliable information to the public or other fellow health professionals thereby reducing the spread of COVID-19 medication misinformation. This can be achieved by providing accurate and reliable information based on recommendations given by relevant health authorities and professional associations to make sure the community understand the importance of the message and thus minimise the detrimental consequences of the pandemic. This commentary aims to summarise the existing literature in relation to the promising treatments currently under trial, the perils of falsified medications and medicine-related information and the role of pharmacists in taking a leading role in combating these parallel global emergencies."],"journal":"Res Social Adm Pharm","authors":["Erku, Daniel A","Belachew, Sewunet A","Abrha, Solomon","Sinnollareddy, Mahipal","Thomas, Jackson","Steadman, Kathryn J","Tesfaye, Wubshet H"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387230","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.sapharm.2020.04.032","keywords":["covid-19","coronavirus","misinformation","pandemics","pharmacists"],"topics":["Prevention"],"weight":1,"_version_":1666428892710174720,"score":193.97433}]}